Marblegate Capital (MGTE) EBITDA Margin (2024 - 2026)
Marblegate Capital's (MGTE) quarterly EBITDA Margin came in at 25.77% in Q2 2026, down 5014.0% on a YoY basis from 0.52% in Q2 2025, and down 684.61% quarter-over-quarter from 4.41% in Q4 2025.
Powered by 
Analysis
Marblegate Capital (MGTE) EBITDA Margin (2024 - 2026) Analysis & Trends
Marblegate Capital (MGTE) has reported EBITDA Margin for 3 consecutive years, with 25.77% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin fell 5014.0% year-over-year to 25.77%; the trailing twelve-month figure through Jun 2026 stood at 0.32% (down 2734.0% YoY), and the FY2025 full-year result was 8.53%, down 2941.0% from the prior year.
- EBITDA Margin slipped to 25.77% in Q2 2026 per MGTE's latest filing, from 4.41% in the prior quarter.
- Across five years, EBITDA Margin topped out at 42.46% in Q3 2024 and bottomed at 25.77% in Q2 2026.
- Historically, EBITDA Margin has averaged 14.27% across 3 years, with a median of 14.16% in 2025.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin soared 560 bps in 2025, then plunged 5014 bps in 2026.
- Over 3 years, EBITDA Margin stood at 31.74% in 2024, then sank by 86 bps to 4.41% in 2025, then tumbled by 685 bps to 25.77% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 25.77%, 4.41%, and 3.87% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.64 Bn | 43.64 Bn | 4.68 Bn | 15.28% |
| 2 | Royalty Pharma | 26.15 Bn | 25.32 Bn | - | 19.75% |
| 3 | Royal Gold | 21.54 Bn | 21.36 Bn | 390.45 Mn | 62.13% |
| 4 | OR Royalties | 6.72 Bn | 6.64 Bn | 82.22 Mn | 64.21% |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | 38.00% |
| 6 | Atlanticus Holdings | 1.41 Bn | 857.38 Mn | 686.46 Mn | 71.06% |
| 7 | Jefferson Capital | 1.18 Bn | 1.15 Bn | - | 45.87% |
| 8 | Upbound | 1.06 Bn | 953.54 Mn | 594.84 Mn | 4.66% |
| 9 | Lufax Holding | 1.05 Bn | -1.58 Bn | - | -13.46% |
| 10 | Marblegate Capital | 76.87 Mn | 68.29 Mn | - | -25.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.77% |
| Dec 31, 2025 | 4.41% |
| Sep 30, 2025 | -3.87% |
| Jun 30, 2025 | 24.37% |
| Mar 31, 2025 | 14.16% |
| Dec 31, 2024 | 31.74% |
| Sep 30, 2024 | 42.46% |
| Jun 30, 2024 | 32.36% |
| Mar 31, 2024 | 8.56% |